We are live on ! Find out more
VKTXW

Viking Therapeutics, Inc.
VKTXW

Delisted

VKTXW was delisted on the 8th of April, 2021.

Back to rankings

1 hedge funds and large institutions have $51K invested in Viking Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$53K
Puts
–
Net Calls
+$53K
Net Calls Change
+$53K

Top Buyers

1
SM
Sabby Management
Florida
+$65.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$51K +$65.9K +176,113 New

VKTXW Hedge Fund Activity: Q2 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q2 2016, worth a combined $51K.

Buyers outnumbered sellers: 1 fund opened new VKTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $65.9K.

  • 1 institutional investor held Viking Therapeutics, Inc. (VKTXW) as of Q2 2016, up from 0 in Q1 2016.
  • Funds reported $51K of Viking Therapeutics, Inc. stock for Q2 2016.
  • 1 fund opened new Viking Therapeutics, Inc. positions in Q2 2016 and 0 closed out, a net change of +1 holder.
  • The largest Viking Therapeutics, Inc. buyer in Q2 2016 was Sabby Management, an estimated $65.9K added.

Based on aggregated 13F filings for Q2 2016.